1. Introduction {#sec1}
===============

Hearing loss (HL) is a common disorder, and congenital hearing impairment affects nearly 1 in every 1000 live births; it is one of the most distressing disorders and the most frequent birth defect in developed societies \[[@B1]\]. Hearing impairment affects speech development, language acquisition, and education in children and, as a result, often leads to decreased opportunities in work life as those with hearing loss move to isolating themselves from society. In the US, it is estimated that the social costs of untreated hearing loss over the course of a lifetime can reach up to \$1.1 million for every untreated person \[[@B2]\]. These costs could be decreased by 75 percent with early intervention and treatment \[[@B3]\].

Hereditary hearing loss accounts for almost 50% of all congenital sensorineural hearing loss cases, and it is caused by genetic mutations \[[@B4]\]. Deafness can be the result of a mutation in a single gene or a combination of mutations of different genes; it can also be a result of environmental causes such as trauma, medications, medical problems, and environmental exposure or the result of an association between environmental factors and genetics \[[@B5]\].

HL can be either nonsyndromic, which is restricted to the inner ear, or syndromic, a part of multiple anomalies affecting the body. Nonsyndromic HL can further be categorised by its mode of inheritance. Approximately 20% of nonsyndromic sensorineural hearing loss (NSSHL) is inherited as autosomal dominant, which is also referred to as DFNA; this type of hearing loss is usually delayed onset. Eighty percent of inherited HL is autosomal recessive (DFNB), in which hearing loss is generally congenital, but some forms may emerge later in life. The inheritance of the remaining types of HL is either mitochondrial or X-linked (DFN) (less than 1 percent) \[[@B2]\]. To date, 125 deafness loci have been reported in the literature: 58 DFNA loci, 63 DFNB loci, and 4 X-linked loci (<http://hereditaryhearingloss.org/>) \[[@B6]\].

Many genes are involved in inner-ear function, and the ear is very sensitive to mutations in genetic loci. This is because the physiology and structure of the inner ear are unique and unlike other anatomical locations. Mutations in genes that control the adhesion of hair cells, intracellular transport, neurotransmitter release, ionic hemeostasis, and cytoskeletons of hair cells can lead to malfunctions of the cochlea and inner ear.

In recent years, with the increase in studies of genes involved in congenital hearing loss, genetic counselling and treatment options have emerged and increased in availability. In diagnostic tests, genes that are common causes of hearing loss, such as*GJB2*,*GJB6*,*SLC26A4*, and*OTOF*, are frequently involved \[[@B7]\]. The results of these tests can be used when counselling parents about the prognosis of a child\'s hearing loss, predicting recurrence in the future offspring and taking into consideration therapeutic options like cochlear implantation \[[@B2]\]. In recent studies, some viral vectors were delivered into the inner ear to replace the normal copy of the gene with the defective gene causing hearing loss. In an animal study, an adenovirus-delivered*SLC17A8* (VGLUT-3; vesicular glutamate transporter 3) was found to restore hearing in the mice. In another study, hair cell development and regeneration were induced by delivering the*ATOH1* gene \[[@B8], [@B9]\].

This minireview has presented an overview and described the currently known genes associated with nonsyndromic congenital hearing loss and mutations that cause malfunctional proteins in the inner ear ([Table 1](#tab1){ref-type="table"}).

2. Genes and Proteins Related to Nonsyndromic Hearing Loss {#sec2}
==========================================================

2.1. Adhesion Proteins {#sec2.1}
----------------------

The stereocilia of hair cells in the cochlea are linked and interconnected to the tectorial membrane by different adhesion proteins. Hair bundles are stabilized by a set of temporary links such as transient lateral links and ankle links. These links also induce growth and maturation with signalling complexes \[[@B10]\]. In mature hair cells, stereocilia are connected by tectorial attachment crowns, horizontal top connectors, and tip links \[[@B2]\]. To date, several genes related to the linking apparatus have been reported. These are DFNA4 (*CEACAM16* (carcinogenic antigen-related cell adhesion molecule 16)) \[[@B11]\], DFNB12 (*CDH23* (cadherin 23)) \[[@B12]\], DFNB16 (*STRC* (stereocilin)) \[[@B13]\], DFNB18 (*USH1C* (harmonin)) \[[@B14], [@B15]\], DFNB22 (*OTOA* (otoancorin)) \[[@B16]\], DFNB23 (*PCDH15* (protocadherin 15)) \[[@B17]\], DFNB31 (*WHRN* (whirlin)) \[[@B18]\], DFNB66/67 (*TMHS* (tetraspan membrane protein)) \[[@B19]\], and DFNB84 (*PTPRQ* (tyrosine phospate receptor Q)) \[[@B20]\].

The*PTPRQ* and*TMHS* genes, as well as cadherin 23 and protocadherin 15, are parts of the transient lateral link. During development, they prevent the fusion of each stereocilium themselves \[[@B2]\]. In mature hair cells, they become the main parts of the tip link and act as a gate, channelling mechanotransduction and providing stability, taking a central role in auditory function \[[@B21]\].

Whirlin and harmonin regulate the link complexes and serve as scaffolding proteins. Mutations in these proteins cause autosomal recessive type hearing loss, but Sans, which is a third scaffolding protein, is related to a complex syndromic hearing loss, Usher syndrome. The other genes,*USH2α* and*VLGR1b*, are also associated with Usher syndrome, and they are part of the stereocilial ankle link \[[@B22]\].

Stereocilin is an extracellular matrix protein that attaches the tallest stereocilia of the outer hair cells to the tectorial membrane \[[@B13]\]. The attachment site of this tectorial membrane is generally formed by*CEACAM16*. In a similar way, otoancrin also attaches nonsensory cells to the tectorial membrane \[[@B16]\].

2.2. Transport Proteins {#sec2.2}
-----------------------

In the inner ear, all parts of the myosin family can be used for the transportation of different proteins. When using ATP, these myosin proteins bind to the actin cytockeleton and move forward. Binding sites for carried proteins are on the carboxyl-terminal tails of the transport proteins \[[@B23]\]. The myosins related to hereditary hearing loss are myosin Ia (DFNA48) \[[@B24]\], myosin IIIa (DFNB30) \[[@B25]\], myosin VI (DFNA22/DFNB37) \[[@B26], [@B27]\], myosin VIIa (DFNA11/DFNB2) \[[@B28], [@B29]\], nonmuscle myosin heavy chain IX (DFNA17) \[[@B30]\], nonmuscle myosin heavy chain XIV (DFNA4) \[[@B31]\], and myosin XVa (DFNB3) \[[@B32]\]. They all have their own unique functions in the inner-ear hair cells \[[@B2]\].

2.3. Proteins of Synapses {#sec2.3}
-------------------------

VGLUT3, which is a vesicular glutamate receptor, plays a role in the inner hair cells\' synapses. It is encoded by*SLC17A8* in the DFNA25 locus and related to autosomal recessive hearing loss \[[@B33]\]. This protein regulates both the exocytosis and the endocytosis of glutamate. Otoferlin (encoded by*OTOF*) is a protein that works with myosin VI at the synaptic cleft of the inner hair cell and plays a role in the calcium-dependent fusion of vesicles to the plasma membrane. As a result, glutamate is released and the afferent neuron is excited \[[@B34]\]. In an animal study with*OTOF* and*SLC17A8* knockout mice, there was a reduction in the number of postsynaptic ganglion cells, and it was concluded that these proteins are very important for the preservation and development of normal hearing \[[@B35]\].

2.4. Electromotility {#sec2.4}
--------------------

The cochlea is sensitive and selective to sounds delivered by the outer hair cells. This is introduced with a process called electromotility, and a protein called Prestin is thought to be responsible for this \[[@B2]\]. It changes the membrane\'s potential and enables the outer hair cell length to be altered. When this occurs, the outer hair cell becomes longer upon hyperpolarization and shorter upon depolarization, so it amplifies its sensitivity to the sound \[[@B36]\]. This protein is encoded as*SLC26A5* and was first described by Zheng et al. in 2000 \[[@B37]\]. Mutations in*SLC26A5* are the cause of DFNB61 hearing loss \[[@B38]\].

2.5. Cytoskeleton {#sec2.5}
-----------------

Mutations in some genes associated with the organisation of the cytoskeleton can cause NSSHL; these are*ESPN* (espin),*RDX* (radixin),*TRIOBP* (trio-binding protein),*ACTG1* (*γ*-actin),*TPRN* (taperin),*DIAPH1* (diaphanous), and*SMPX* (small muscle protein, X-linked).

The protein espin provides stability to the stereocilial cytoskeleton. A mutation in*ESPN* can cause DFNB36 and autosomal dominant hearing loss \[[@B39]\]. More steriocillia stability can be achieved with radixin. It links actin filaments to the plasma membrane and presents along the stereocilia. Mutations in*RDX* can cause DFNB24 and autosomal recessive deafness \[[@B40]\]. *γ*-actin acts as a building block for the stereocilia of hair cells. These stereocilia are constantly undergoing depolymerisation at the base and actin polymerisation at the tip \[[@B41]\]. Mutations in*ACTG1* can cause DFNA20/26 and autosomal dominant hearing loss \[[@B42], [@B43]\]. Via a constant remodelling process, other proteins are also important for continuity. Diaphanous 1 regulates the reorganisation and polymerisation of actin monomers into polymers. It is encoded as*DIAPH1*, and mutations in this gene can cause DFNA1 and autosomal dominant hearing loss \[[@B44]\]. The binding and organisation of *γ*-actin at the base of stereocilia are provided by two isoforms of the*TRIOBP* gene. Mutations in isoforms that are*TRIOBP4* and*TRIOBP5* can cause DFNB28 and autosomal recessive type hearing loss \[[@B45], [@B46]\]. Another protein, taperin, is localised in the base of the stereocilia and associated with DFNB79 \[[@B47]\]. Small muscle protein X-linked, encoded as*SMPX* (DFN4), has a function in stereocilial development and maintenance in response to the mechanical stress to which stereocilia are subjected \[[@B48]\].

2.6. Ion Homeostasis and Gap Junctions {#sec2.6}
--------------------------------------

The cochlea has two types of fluids: perilymph, which is high in sodium and low in potassium, and endolymph, which is high in potassium and low in sodium; this condition makes a highly positive potential (+80 mV) called endocochlear potential. Potassium influx into the hair cells causes depolarisation and, after that, the hair cell repolarises and moves cations back into the endolymph. This ion homeostasis involves tight junction protein 2 (*TJP2*), tricellulin (*MARVELD2*/*TRIC*), claudin 14 (CLDN14), KCNQ4 (*KCNQ4*), Barttin (*BSND*), ATP2b2 (*ATP2b2*/*PMCA2*), some connexins (*GJBs*), and pendrin (*SLC26A4*), and they are all related to hereditary hearing loss \[[@B2]\].

In a mutation of*CLDN14* in DFNB29, claudin 14 protein will be absent or dysfunctional, and the space of Nuel that surrounds the basolateral surface of outer hair cells is affected and might change its electrical potential \[[@B49]\]. Similarly, tricellulin, which is encoded as*MARVELD2*/*TRIC*, causes DFNB49 when mutated, and it is functioning as tight junction that connects the cells together \[[@B45]\]. Tight junction protein 2, encoded as the*TJP2* gene, binds tight junctions to the actin cytoskeleton, and mutations cause DFNA51 and autosomal dominant type hearing loss \[[@B50]\].

*KCNQ4* encodes a protein forming a voltage-gated potassium channel. It is expressed in outer hair cells and, if mutated, causes an autosomal dominant type HL, DFNA2a \[[@B51]\]. It aids in the repolarisation of outer hair cells and regulates the sensitivity to sound.

Barttin and pendrin, encoded as*BSND* and*SLC26A4*, respectively, are involved in both nonsyndromic and syndromic HL. Pendrin is an anion exchanger and plays a crucial role in the acid-base balance. Both syndromic (Pendred\'s syndrome, associated with goiter) and nonsyndromic HL (DFNB4) are related to the extent of the mutation in*SLC26A4* \[[@B52]\]. Barttin protein is one of the subunits of the chloride channel. Mostly, mutations in*BSND* can cause Bartter syndrome, associated with hearing loss and renal abnormalities, but DFNB73 has also been attributed to a mutation in*BSND* and causing nonsyndromic deafness \[[@B53]\].

A gap junction is a channel extending over two adjacent membranes that enables the exchange of various molecules and ions in the cochlea. These junctions are made up of proteins called connexins. These junctions also play a role in the recycling of potassium ions needed for normal hearing. it is the most common cause of nonsyndromic HL and was the first identified gene is*GJB2;* it is encoded as connexin 26 (DFNA3a/DFNB1a) \[[@B54]\]. Other connexins related to nonsyndromic HL are connexin 30 (*GJB6*, DFNA3b/DFNB1b) \[[@B55], [@B56]\] and connexin 31 (*GJB3*, DFNA2b/DFNB91) \[[@B57], [@B58]\].

2.7. Others {#sec2.7}
-----------

There are also extracellular matrix proteins, that is,*TECTA* (*α*-tectorin),*COL11A2* (type XI collagen *α*2), and*COCH* (cochlin), and transcription factors, such as*POU4f3* (class 4 POU),*POU3f4* (class 3 POU),*MIR96* (microRNA 96),*GRHL2* (grainy-head-like 2),*ESRRB* (oestrogen-related receptor *β*), and*EYA4* (eyes absent 4) involved in hereditary HL.

3. Conclusion {#sec3}
=============

This review presents an overview and description of the currently known genes related to hereditary NSSHL. The functions of these genes will be better understood with time, and more genes leading to hearing loss will be discovered soon. With new studies and continued examination, the function of the cochlea will be better understood, and novel molecular and gene therapies for human sensorineural HL will hopefully be developed.
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Genes related with nonsyndromic hearing loss.

  Locus                Gene           Chromosomal localization   Type of inheritance                            Protein                                                                                                                Function                                                                Reference
  -------------------- -------------- -------------------------- ---------------------------------------------- ---------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------- --------------------
  DFNA1                DIAPH1         5q31                       AD                                             Diaphanous 1                                                                                                           Actin polymerisation (cytoskeleton)                                     \[[@B44]\]
  DFNA2A               KCNQ4          1p34                       AD                                             KCNQ4                                                                                                                  Voltage-gated K^+^ channel (ion haemostasis)                            \[[@B51]\]
  DFNA2B               GJB3 (Cx31)    1p34                       AD                                             Connexin 31                                                                                                            Gap junction (ion haemostasis)                                          \[[@B57]\]
  DFNA3A               GJB2 (Cx26)    13q12                      AD                                             Connexin 26                                                                                                            Gap junction (ion haemostasis)                                          \[[@B54]\]
  DFNA3B               GJB6 (Cx30)    13q12                      AD                                             Connexin 30                                                                                                            Gap junction (ion haemostasis)                                          \[[@B55]\]
  DFNA4                MYH14          19q13                      AD                                             Nonmuscle myosin heavy chain XIV                                                                                       Transport                                                               \[[@B31]\]
  DFNA4                CAECAM16       19q13                      AD                                             Carcinogenic antigen-related cell adhesion molecule 16                                                                 TM attachment crown (adhesion)                                          \[[@B11]\]
  DFNA8/12             TECTA          11q22-24                   AD                                             A-tectorin                                                                                                             Stability and structure of TM (ECM)                                     \[[@B28]\]
  DFNA9                COCH           14q12-q13                  AD                                             Cochlin                                                                                                                Structure of spiral limbus                                              \[[@B30]\]
  DFNA10               EYA4           6q22-q23                   AD                                             Eyes absent 4                                                                                                          Regulation of transcription (transcription factor)                      \[[@B42]\]
  DFNA11               MYO7A          11q12.3-q21                AD                                             Myosin VIIa                                                                                                            Transport                                                               \[[@B43]\]
  DFNA13               COLL11A2       6p21                       AD                                             Type XI collagen *α*2                                                                                                  Stability and structure of TM (ECM)                                     \[[@B26]\]
  DFNA15               POU3F4         5q31                       AD                                             Class 3 POU                                                                                                            Regulation of transcription (transcription factor)                      \[[@B33]\]
  DFNA17               MYH9           22q                        AD                                             Nonmuscle myosin heavy chain IX                                                                                        Transport                                                               \[[@B24]\]
  DFNA20/26            ACTG1          17q25                      AD                                             *γ*-actin                                                                                                              Building cytoskeleton (cytoskeleton)                                    \[[@B50], [@B56]\]
  DFNA22               MYO6           6q13                       AD                                             Myosin VI                                                                                                              Regulation of exocytosis, anchoring stereocilia (cytoskeleton)          \[[@B29]\]
  DFNA25               SLC17A8        12q21-24                   AD                                             VGLUT-3                                                                                                                Regulation of exocytosis and endocytosis of glutamate (transport)       \[[@B32]\]
  DFNA28               TFCP2L3        8q22                       AD                                             Transcription factor CP2-like 3                                                                                        Regulation of transcription (transcription factor)                      \[[@B52]\]
  DFNA48               MYO1A          12q13-q14                  AD                                             Myosin Ia                                                                                                              Transport                                                               \[[@B34]\]
  DFNA50               MIR96          7q32                       AD                                             MicroRNA96                                                                                                             Regulation of transcription (transcription factor)                      \[[@B12]\]
  DFNA51               TJP2                                      AD                                             Tight junction protein 2                                                                                               Cell cycle signaling, binding tight junctions to membrane               \[[@B13]\]
  DFNA56               TNC            9q31.3-q34.3               AD                                             Tenascin-C                                                                                                             Stability and structure of TM (ECM)                                     \[[@B14]\]
  DFNA64               SMAC/DIABLO    12q24.31-12q24.32          AD                                             Second Mitochondria-Derived Activator of Caspase/Direct Inhibitor of Apoptosis protein Binding protein with a low pI   Cell cycle signaling                                                    \[[@B15]\]
  DFNA65               TBC1D24        16p13.3                    AD                                             Tbc1 domain family, member 24                                                                                          Encoding a GTPase-activating protein expressed in the cochlea           \[[@B16], [@B17]\]
  DFNA67               OSBPL2         20q13.2-q13.33             AD                                             Oxysterol-binding Protein-like Protein 2                                                                               Intracellular transport of lipids, particularly oxysterol (transport)   \[[@B40], [@B45]\]
  HOMER2               15q25.2        AD                         Homer, drosophila, homolog of 2                Negative regulator of T cell activation                                                                                \[[@B46]\]                                                              
  DFNB1A               GJB2 (Cx26)    13q11-q12                  AR                                             Connexin 26                                                                                                            Gap junction (ion haemostasis)                                          \[[@B13]\]
  DFNB1B               GJB6 (Cx30)    13q12                      AR                                             Connexin 30                                                                                                            Gap junction (ion haemostasis)                                          \[[@B49]\]
  DFNB2                MYO7A          11q                        AR                                             Myosin VIIa                                                                                                            Transport                                                               \[[@B25], [@B43]\]
  DFNB3                MYO15A         17p11.2                    AR                                             Myosin Xva                                                                                                             Transport                                                               \[[@B18]\]
  DFNB4                SLC26A4        7q31                       AR                                             Pendrin                                                                                                                Acid-base balance of endolymph (ion haemostasis)                        \[[@B39]\]
  DFNB9                OTOF           2p23-p22                   AR                                             Otoferlin                                                                                                              Fusion of synaptic vesicles with Ca^+2^ (transport)                     \[[@B38]\]
  DFNB12               CDH23          10q21-q22                  AR                                             Cadherin 23                                                                                                            Lateral and tip link (adhesion)                                         \[[@B19]\]
  Modifier of DNFB12   ATP2b2/PMCA2   1p32.3                     AR                                             ATP2b2                                                                                                                 ATP dependent Ca^+2^ pump                                               \[[@B53]\]
  DFNB16               STRC           15q15                      AR                                             Stereocilin                                                                                                            TM attachment links (adhesion)                                          \[[@B20]\]
  DFNB18               USH1C          11p15.1                    AR                                             Harmonin                                                                                                               Scaffolding protein (adhesion)                                          \[[@B48], [@B58]\]
  DFNB21               TECTA          11q22-q24                  AR                                             *α*-tectorin                                                                                                           Stability and structure of TM (ECM)                                     \[[@B10]\]
  DFNB22               OTOA           16p12.2                    AR                                             Otoancorin                                                                                                             TM attachment to nonsensroy cells (adhesion)                            \[[@B21]\]
  DFNB23               PCDH15         10q21-q22                  AR                                             Protocadherin 15                                                                                                       Lateral and tip link (adhesion)                                         \[[@B22]\]
  DFNB24               RDX            11q23                      AR                                             Radixin                                                                                                                Actin binding to plasma membrane (cytoskeleton)                         \[[@B23]\]
  DFNB28               TRIOBP         22q13.1                    AR                                             Trio-binding protein                                                                                                   Actin binding and organisation (cytoskeleton)                           \[[@B27], [@B35]\]
  DFNB29               CLDN14         21q22.3                    AR                                             Claudin 14                                                                                                             Tight junction (ion haemostasis)                                        \[[@B36]\]
  DFNB30               MYO3A          10p11.1                    AR                                             Myosin IIIa                                                                                                            Transport                                                               \[[@B37]\]
  DFNB31               WHRN           9q32-q34                   AR                                             Whirlin                                                                                                                Scaffolding protein (adhesion)                                          \[[@B41]\]
  DFNB35               ESRRB          14q21.1-q24.3              AR                                             Oestrogen-related receptor *β*                                                                                         Regulation of transcription (transcription factor)                      \[[@B47]\]
  DFNB36               ESPN           1p36.3-p36.1               AR                                             Espin                                                                                                                  Actin crosslinking and bundling (cytoskeleton)                          \[[@B59]\]
  DFNB37               MYO6           6q13                       AR                                             Myosin VI                                                                                                              Regulation of exocytosis, stereocilia anchoring (transport)             \[[@B60]\]
  DFNB49               TRIC           5q12.3-q14.1               AR                                             Tricellulin                                                                                                            Tight junction (ion haemostasis)                                        \[[@B53]\]
  DFNB53               COL11A2        6p21.3                     AR                                             Type XI collagen *α*2                                                                                                  Stability and structure of TM (ECM)                                     \[[@B61]\]
  DFNB61               SLC26A5                                   AR                                             Prestin                                                                                                                Electromotility                                                         \[[@B62]\]
  DFNB67               TMHS           6p21.3                     AR                                             Tetraspan membrane protein                                                                                             Transient link (adhesion)                                               \[[@B63]\]
  DFNB73               BSND                                      AR                                             Barttin                                                                                                                K^+^ channel maturation and trafficking (ion haemostasis)               \[[@B64]\]
  DFNB79               TPRN           9q34.3                     AR                                             Taperin                                                                                                                Actin regulation (cytoskeleton)                                         \[[@B65]\]
  DFNB84               PTPRQ          12q21.31-q21.2             AR                                             Protein tyrosine phosphate receptor Q                                                                                  Transient link (adhesion)                                               \[[@B66]\]
  DFNB91               GJB3           6p25                       AR                                             Connexin 31                                                                                                            Gap junction (ion haemostasis)                                          \[[@B67]\]
  DFNB93               CABP2          11q13.2                    AR                                             Calcium-binding protein 2                                                                                              (ion haemostasis)                                                       \[[@B68]\]
  DFNB94               NARS2          11q14.1                    AR                                             Asparaginyl-tRNA synthetase 2                                                                                          (transport)                                                             \[[@B69]\]
  DFNB97               MET            7q31.2                     AR                                             MET protooncogene                                                                                                      Cell-surface receptor for hepatocyte growth factor (adhesion)           \[[@B70]\]
  DFNB98               TSPEAR         21q22.3                    AR                                             Thrombospondin-type laminin g domain and ear repeats                                                                   Cell permeabilization (transport)                                       \[[@B71]\]
  DFNB99               TMEM132E       17q12                      AR                                             Transmembrane protein 132e                                                                                             Extracellular receptor                                                  \[[@B72]\]
  DFNB101              GRXCR2         5q32                       AR                                             Glutaredoxin, cysteine-rich 2                                                                                          Organisation of stereocilia (adhesion)                                  \[[@B73]\]
  DFNB102              EPS8           12p12.3                    AR                                             Epidermal growth factor receptor pathway substrate 8                                                                   Regulating Rac-specific GEF activity (transcription factor)             \[[@B74]\]
  DFNB103              CLIC5          6p21.1                     AR                                             Chloride intracellular channel 5                                                                                       (ion haemostasis)                                                       \[[@B75]\]
  FAM65B               6p22.3         AR                         Family with sequence similarity 65, member b   (Cytoskleton)                                                                                                          \[[@B76]\]                                                              
  Usher syndrome       SANS/USH1G     17q24-25                   AR                                             SANS                                                                                                                   Scaffolding protein (adhesion)                                          \[[@B77]\]
  Usher syndrome       USH2A          1q41                       AR                                             Usherin                                                                                                                Ankle link (adhesion)                                                   \[[@B78]\]
  Usher syndrome       VLGR1B                                    AR                                             Very large G protein-coupled receptor 1                                                                                Ankle link (adhesion)                                                   \[[@B79]\]
  DFN2                 PRPS1          Xq22.3                     X-linked                                       Phosphoribosylpyrophosphate synthetase 1                                                                               Purine and pyrimidine biosynthesis                                      \[[@B80]\]
  DFN3                 POU3F4         Xq21                       X-linked                                       Class 3 POU                                                                                                            Regulation of transcription (transcription factor)                      \[[@B81]\]
  DFN6                 SMPX           Xp21.2                     X-linked                                       Small muscle protein X-linked                                                                                          Stereocilial development and maintenance (cytoskeleton)                 \[[@B82]\]
  DFNX6                COL4A6         Xq22.3                     X-linked                                       Collagen, type IV, alpha-6                                                                                             Stability and structure of TM (ECM)                                     \[[@B83]\]

DFNA = nonsyndromic deafness, autosomal dominant; DFNB = nonsyndromic deafness, autosomal recessive; AD = autosomal dominant; AR = autosomal recessive; TM = tectorial membrane; ECM = extracellular matrix; Ca^+2^ = calcium ion; K^+^ = potassium ion.
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